Unlock instant, AI-driven research and patent intelligence for your innovation.

Modified mRNA sequence for increasing uric acid excretion and application thereof

A uric acid and sequence technology, applied in the field of molecular biomedicine, can solve the problems of hindering the reabsorption of proximal convoluted tubules, liver and kidney damage, etc., and achieve the effect of increasing the effect of uric acid excretion, reducing blood uric acid in the body, and having no adverse reactions.

Pending Publication Date: 2021-04-30
QINGDAO UNIV
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

For example, benzbromarone can reduce the level of uric acid by acting on the proximal convoluted tubule of the kidney, efficiently and reversibly exchanging uric acid ions to hinder the reabsorption of the proximal convoluted tubule, thereby promoting the excretion of uric acid, but these chemicals can cause liver and kidney damage and allergies, etc. serious adverse reaction

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Modified mRNA sequence for increasing uric acid excretion and application thereof
  • Modified mRNA sequence for increasing uric acid excretion and application thereof
  • Modified mRNA sequence for increasing uric acid excretion and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0060] Example 1 Construction of the recombinant plasmid pET-28a(+)-ABCG2 carrying the ABCG2 DNA sequence The DNA sequence of mouse ABCG2 was found from NCBI, and the design added 5'UTR and 3'UTR, which contained T7 promoter, Kozak sequence, and Add BamHI and Sal I restriction sites, respectively. The sequence was synthesized by Shanghai Shenggong Company. The synthetic sequence and the pET-28a(+) plasmid were simultaneously digested with BamH I and Sal I. 50μL enzyme digestion system: BamHI 1μL (10U·μL), SalI 1μL (10U·μL), 10×K Buffer 5μL, DNA 20μL, ddH 2 O 23 μL. Constant temperature water bath 37 ℃, 2h. After purification, use T4 DNA ligase to ligate the digested pET-28a(+) plasmid with the target gene fragment, see figure 1 .

Embodiment 2

[0061] Example 2 Enzyme digestion identification of recombinant plasmid pET-28a(+)-ABCG2

[0062] The recombinant plasmid was transformed into Escherichia coli DH5α by heat shock method, spread evenly on the LB screening plate containing kanamycin, and cultured overnight at 37°C. A single colony was shaken to amplify and extract the recombinant plasmid for identification by double-enzyme digestion electrophoresis. The results showed that ABCG2 sequence with 5'UTR and 3'UTR was successfully inserted into pET-28a(+) plasmid. See figure 2 .

Embodiment 3

[0063] Example 3 In vitro transcription of ABCG2 mRNA and Western bolt detection of mRNA protein expression in TCMK-1 cells

[0064] Using the recombinant plasmid pET-28a(+)-ABCG2 as a template, the target gene sequence was amplified by PCR as template DNA for in vitro transcription. 120 Ts were added to the end of the downstream primer sequence for tailing. The PCR product was electrophoresed on 1.2% agarose gel, and the target gene was extracted and purified using a DNA gel extraction kit. The purified DNA samples were sent to Shanghai Sangon Company for sequencing and identification to ensure that the sequences were consistent and the tails were successfully added before in vitro transcription. According to the capping system in the MEGAscript T7 kit instruction manual, the DNA product with poly(T) tail added as a template was transcribed in vitro under the action of T7 RNA polymerase to obtain ABCG2 mRNA, and the mRNA was added with 3′-O-Me - m7G(5')ppp(5')G RNA cap anal...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a modified mRNA sequence for increasing uric acid excretion and application thereof, and relates to the technical field of biomedicine. The ABCG2mRNA can reduce uric acid in mouse renal tubular epithelial cells (TCMK1) and mouse blood, has a potential anti-gout effect, has sequences shown as SEQIDNO.1 and SEQIDNO.2, and has the advantages of low immunogenicity, easiness in in in-vitro synthesis and modification and the like. The technical problem that in the prior art, no one capable of reducing in-vivo blood uric acid in a targeted mode exists is solved.

Description

technical field [0001] The invention relates to the technical field of molecular biomedicine, in particular to a modified mRNA for reducing uric acid and its application and application method. Background technique [0002] Gout is the most common inflammatory arthritis in adults, which is mainly caused by excessive production of uric acid and decreased excretion of uric acid due to disturbance of purine metabolism. Hyperuricemia (Hyperuricemia) is the biochemical precursor of gout, which is defined as the state of normal intake of purine, and the value of fasting blood uric acid on different days is higher than the upper limit of the normal value twice (male>416.4μmol / L, female> 356.9 μmol / L). Tophi forms when sodium urate (MSU) crystals deposit in joints, tendons, cartilage, synovial bursa, or soft tissue. The continuous increase of serum uric acid is the characteristic of hyperuricemia. It is not only one of the metabolic diseases closely related to hypertension, ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N15/12C12N15/88A61K38/17A61P19/06
CPCC07K14/47C12N15/88A61P19/06A61K38/00
Inventor 葛科立孙忠兴葛银林薛美兰张金玉
Owner QINGDAO UNIV